Small Particles, Big Role in Nobel Prize for Physics

This year's winners of the Nobel Prize for physics collectively discovered and described a phenomenon that appears to defy common sense. Fewer notions could be so intuitively valid as the following: smaller things are generated by breaking bigger things apart. The world of physics usually bears this out: An atom, for example, divides into electrons, protons, and neutrons; a proton splits into quarks. But in 1982, Daniel Tsui, a professor of physics at Princeton University, and Horst Stormer, a

Written byEugene Russo
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

This year's winners of the Nobel Prize for physics collectively discovered and described a phenomenon that appears to defy common sense. Fewer notions could be so intuitively valid as the following: smaller things are generated by breaking bigger things apart. The world of physics usually bears this out: An atom, for example, divides into electrons, protons, and neutrons; a proton splits into quarks. But in 1982, Daniel Tsui, a professor of physics at Princeton University, and Horst Stormer, a professor of physics and applied physics at Columbia University and the adjunct director of physical sciences at Bell Laboratories' Physical Science Division in Murray Hill, N.J., observed the impossible. They were looking for something called the electron crystal, an as-yet-unproved theory that electrons will crystallize when placed in strong magnetic fields and low temperatures. In the process, they accidentally discovered that under these same conditions electrons will actually form fractional charges ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies